Rehmannia extract, derived from the root of Rehmannia glutinosa, has been a staple in Traditional Chinese Medicine for over two millennia. As global demand for botanical ingredients continues to grow, manufacturers and supplement brands sourcing this ingredient increasingly ask whether rehmannia extract meets the regulatory standards set by the European Medicines Agency (EMA). The answer is nuanced, and understanding the regulatory landscape is essential for anyone involved in the botanical supply chain.
What Is EMA and How Does It Regulate Herbal Products?
The European Medicines Agency (EMA), through its Committee on Herbal Medicinal Products (HMPC), is responsible for establishing scientific opinions on herbal substances and preparations intended for medicinal use within the European Union. The HMPC publishes EU herbal monographs that serve as harmonized reference documents, summarizing safety and efficacy data for specific herbal substances. These monographs are not marketing authorizations in themselves, but they provide the scientific basis upon which national competent authorities evaluate herbal medicinal product applications.
For a herbal substance to receive an EU monograph, it must meet one of two criteria: either well-established medicinal use with recognized efficacy and acceptable safety supported by published scientific literature, or traditional use within the EU for at least 30 years, including at least 15 years of use within the EU itself. This dual pathway creates a distinct challenge for botanicals like rehmannia that have deep roots in Asian medical traditions but limited historical presence in European practice.
Current EMA Status of Rehmannia Extract
As of 2026, Rehmannia glutinosa and its extract preparations do not have an EU herbal monograph published by the HMPC. The EMA's priority list for herbal substances — a regularly updated document that tracks substances under assessment — does not currently include rehmannia among its active or planned evaluation entries. This means that rehmannia extract has not been formally assessed by the HMPC, and no EU-level harmonized monograph exists for this botanical ingredient.
This absence does not mean rehmannia extract is prohibited in the EU, but it does mean that the ingredient cannot be placed on the EU market under a simplified registration procedure based on an EU monograph. Instead, it must navigate alternative regulatory frameworks depending on the intended use of the final product.
Regulatory Pathways for Rehmannia Extract in the EU Market
The regulatory route for rehmannia extract in the Europeanｕｎｉｏｎdepends entirely on the product category in which it will be used. The following table summarizes the three main pathways:
| Product Category | Applicable Regulation | Key Requirements |
|---|---|---|
| Herbal Medicinal Product | Directive 2004/24/EC (THMPD) | Full or traditional-use registration through a national competent authority; requires proof of 30 years of medicinal use (15 within EU) or well-established use data |
| Food / Dietary Supplement | EU Novel Food Regulation (EU 2015/2283) | Novel Food authorization required if not consumed to a significant degree in the EU before May 1997; rehmannia extract is not listed in the EU Traditional Use Food Catalogue |
| Cosmetic Ingredient | EU Cosmetics Regulation (EC) No 1223/2009 | Must be safe under normal and reasonably foreseeable use; responsibility lies with the manufacturer or importer; no pre-market authorization required but full safety dossier recommended |
For food and dietary supplement applications, rehmannia extract faces a significant hurdle: it is not included in the EU Traditional Use Food Catalogue. This means importers must complete a declaration and obtain approval under the EU Novel Food Regulation before the ingredient can be sold legally as a food or dietary supplement raw material in the EU. The Novel Food authorization process requires comprehensive safety data, including toxicological studies and evidence of safe history of use, and can take 18 to 36 months from submission to approval.
In the cosmetics sector, the path is comparatively more straightforward. Rehmannia extract is listed in the EU CosIng database as a cosmetic ingredient, and as long as the manufacturer or responsible person ensures the ingredient is safe under normal conditions of use, it can be incorporated into cosmetic formulations without pre-market authorization.
Quality Standards That Support EMA-Aligned Compliance
Even without a specific EMA monograph, a botanical extracts manufacturer can demonstrate alignment with EU regulatory expectations by adhering to recognized quality frameworks. These include:
- Good Manufacturing Practice (GMP): Compliance with EU GMP guidelines (EudraLex Volume 4) for active substances used as starting materials in medicinal products is essential. This includes documented procedures for sourcing, extraction, purification, and quality control.
- Pharmacopoeial Standards: While no specific monograph exists for rehmannia extract in the European Pharmacopoeia, manufacturers can apply general monograph requirements for herbal extracts and demonstrate analytical method validation according to ICH Q2(R1) guidelines.
- ISO Certifications: ISO 9001 quality management systems and ISO 22000 food safety management provide a foundational quality infrastructure recognized by EU authorities.
- Comprehensive Analytical Testing: HPLC-based quantification of marker compounds such as catalpol and verbascoside, combined with heavy metal analysis (lead, cadmium, arsenic, mercury), pesticide residue screening per EU MRLs, and microbiological testing, forms the backbone of a defensible quality dossier.
For companies sourcing botanical extracts for supplements destined for the EU market, it is critical to partner with suppliers who can provide full Certificates of Analysis, batch traceability documentation, and evidence of compliance with internationally recognized quality systems.
How Cactus Botanics Supports Regulatory Readiness
Cactus Botanics operates a global manufacturing ecosystem with facilities in the United States, Germany, and China, all managed under GMP requirements and standard operating procedures from botanical sourcing through final packaging. The company holds ISO 9001, FSSC 22000, cGMP, USDA Organic, EU Organic, Kosher, and Halal certifications — a portfolio that demonstrates cross-functional compliance with international quality expectations.
For rehmannia extract specifically, Cactus Botanics offers rehmanniae powder extract as part of its finished products line. The extract is produced using controlled extraction processes and is supported by analytical testing capabilities that include HPLC, UV, GC, TLC, and DNA testing where required. This level of characterization is precisely what regulatory authorities expect when evaluating the quality and safety of botanical ingredients.
While Cactus Botanics does not provide regulatory legal advice, the company's documentation package — including detailed certificates of analysis, stability data, and traceability records — provides downstream customers with the evidence base needed to support their own regulatory submissions, whether for Novel Food authorization, THMPD traditional-use registration, or cosmetic product safety assessments.
Practical Steps for Importers and Formulators
If you are considering importing rehmannia extract into the EU, the following practical steps will help you navigate the compliance landscape:
- Determine the intended use category early. The regulatory pathway for a cosmetic ingredient differs fundamentally from that of a food supplement or a medicinal product. Define the product category before initiating the sourcing process.
- Engage with a qualified EU regulatory consultant. The Novel Food application process and THMPD registration are complex and require specialized expertise. Professional guidance can significantly reduce time to market.
- Work with a manufacturer that provides comprehensive documentation. A supplier that can deliver full analytical data, stability studies, and quality system certifications reduces the regulatory burden on the importer.
- Monitor the EMA HMPC priority list. The regulatory landscape evolves over time. If rehmannia extract is added to the HMPC work program, the pathway to an EU monograph could open, potentially simplifying future market access.
Conclusion
Rehmannia extract is not currently EMA-compliant in the sense of having an HMPC herbal monograph or a recognized regulatory status under EU food law. However, this does not preclude its use in the European market. For cosmetic applications, the path is relatively open. For food and dietary supplement uses, a Novel Food authorization is required. For medicinal applications, a full or traditional-use registration through a national competent authority is necessary. In all cases, working with a quality-driven botanical extracts manufacturer that provides robust analytical documentation is the foundation of any successful regulatory strategy. The key is not whether rehmannia extract is EMA compliant today, but whether your supply chain and documentation are strong enough to support the regulatory pathway you choose.
